Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis

Factor XIII is one of the twelve coagulation factors and also known as a fibrin-stabilizing factor. In 2012, we encountered a male RA patient with hemorrhagic factor XIII deficiency who had been treated with tocilizumab for two years. There are few reports regarding the relationship between tocilizu...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Mokuda, Sho, Murata, Yosuke, Sawada, Naoya, Matoba, Kenichiro, Yamada, Akihiro, Onishi, Makoto, Okuda, Yasuaki, Jouyama, Kazuo, Sugiyama, Eiji, Takasugi, Kiyoshi
التنسيق: Artigo
اللغة:Inglês
منشور في: Public Library of Science 2013
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731329/
https://ncbi.nlm.nih.gov/pubmed/23936360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0069944
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة